Table 1.
Patient characteristics among 334 advanced HGSOC patients.
| Characteristic | |
|---|---|
| Age at surgery (years), mean (SD) | 63.5 (11.4) |
| ASA score | |
| <3 | 174(52.1%) |
| ≥3 | 160 (47.9%) |
| Preoperative albumin (% of 179) | |
| ≥3.5 g/dL | 140 (78.2%) |
| <3.5 g/dL | 39 (21.8%) |
| FIGO stage | |
| IIIA/B | 27 (8.1%) |
| IIIC | 228 (68.3%) |
| IV | 79 (23.7%) |
| Residual disease (% of 323) | |
| 0 cm | 101 (31.3%) |
| 0.1–0.5 cm | 131 (40.6%) |
| 0.6–1.0 cm | 36 (11.1%) |
| >1.0 cm | 55 (17.0%) |
| Surgical complexity (% of333) | |
| Low | 67 (20.1%) |
| Intermediate | 157 (47.1%) |
| High | 109 (32.7%) |
| Intraperitoneal dissemination pattern | |
| Pelvic | 29 (8.7%) |
| Lower abdominal | 48 (14.4%) |
| Upper abdominal/miliary | 257 (76.9%) |
| Molecular subtype | |
| Proliferative | 92 (27.5%) |
| Differentiated | 73 (21.9%) |
| Mesenchymal | 94 (28.1%) |
| Immunoreactive | 75 (22.5%) |
Abbreviations: ASA, American Society of Anesthesiologists; FIGO, International Federation of Gynecology and Obstetrics; HGSOC, high-grade serous ovarian cancer.